Rapidly detect SARS-CoV-2, including emerging variants, to provide timely and effective results
Accurately detect respiratory tract infections to ensure appropriate patient treatment
Rapidly differentiate Flu A, Flu B, RSV, and SARS-CoV-2. Identify potential cases of co-infections during respiratory season.
The Solution
Robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP to offer broader coverage against mutations.
Rapid sample to answer provides actionable results from a single sample with less than one minute of hands-on time.
Standardization of results between the central lab and decentralized testing sites.
The Impact
Ensures that patients receive appropriate treatment in a timely manner.
Supports clinicians with broader coverage for variants.
Single cartridge with an easy-to-use workflow, enabling hospitals to effectively manage limited resources.